US6057287A
(en)
|
1994-01-11 |
2000-05-02 |
Dyax Corp. |
Kallikrein-binding "Kunitz domain" proteins and analogues thereof
|
US20020064546A1
(en)
*
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
AU4648697A
(en)
|
1996-09-23 |
1998-04-14 |
Chandrashekar Pathak |
Methods and devices for preparing protein concentrates
|
US8003705B2
(en)
|
1996-09-23 |
2011-08-23 |
Incept Llc |
Biocompatible hydrogels made with small molecule precursors
|
US6258351B1
(en)
*
|
1996-11-06 |
2001-07-10 |
Shearwater Corporation |
Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
|
US7642323B2
(en)
|
1997-11-06 |
2010-01-05 |
Nektar Therapeutics |
Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
|
US6448369B1
(en)
|
1997-11-06 |
2002-09-10 |
Shearwater Corporation |
Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
|
US6362276B1
(en)
*
|
1998-01-07 |
2002-03-26 |
Debio Recherche Pharmaceutique S.A. |
Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
|
US7335220B2
(en)
|
2004-11-05 |
2008-02-26 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
GB2341185A
(en)
*
|
1998-09-07 |
2000-03-08 |
Polybiomed Ltd |
Polymerizable material and adhesive sheet material therefrom; dressings, electrodes and transdermal patches
|
WO2000015117A1
(en)
|
1998-09-17 |
2000-03-23 |
Focal, Inc. |
Self-cleaning fluid delivery device for medical applications
|
ES2632564T3
(es)
|
1999-02-01 |
2017-09-14 |
Eidgenössische Technische Hochschule Zürich |
Bio-materiales formados por reacción de adición nucleófila a grupos insaturados conjugados
|
US6958212B1
(en)
|
1999-02-01 |
2005-10-25 |
Eidgenossische Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
US6828412B1
(en)
*
|
1999-09-03 |
2004-12-07 |
School Of Pharmacy, University Of London |
Degradable polymers
|
US7037992B2
(en)
*
|
1999-09-29 |
2006-05-02 |
Sri International |
Olefin copolymers containing hydrolytically cleavable linkages and use thereof in degradable products
|
US6288184B1
(en)
*
|
1999-09-29 |
2001-09-11 |
Sri International |
Hydrolytically degradable olefin copolymers
|
AU781336B2
(en)
*
|
1999-10-08 |
2005-05-19 |
Nektar Therapeutics |
Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
|
AU781839B2
(en)
*
|
1999-12-22 |
2005-06-16 |
Nektar Therapeutics |
Sterically hindered derivatives of water soluble polymers
|
US7291673B2
(en)
|
2000-06-02 |
2007-11-06 |
Eidgenossiche Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
EP1324779B1
(de)
|
2000-09-29 |
2011-07-20 |
Schering Corporation |
Pegyliertes interleukin 10
|
EP1355965B1
(de)
|
2000-10-19 |
2012-09-19 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Verfahren zur herstellung von blockcopolymeren für multifunktionelle selbstorganisierende systeme
|
US7829074B2
(en)
|
2001-10-18 |
2010-11-09 |
Nektar Therapeutics |
Hydroxypatite-targeting poly(ethylene glycol) and related polymers
|
TWI246524B
(en)
*
|
2001-01-19 |
2006-01-01 |
Shearwater Corp |
Multi-arm block copolymers as drug delivery vehicles
|
US7265186B2
(en)
*
|
2001-01-19 |
2007-09-04 |
Nektar Therapeutics Al, Corporation |
Multi-arm block copolymers as drug delivery vehicles
|
GB0116143D0
(en)
*
|
2001-07-02 |
2001-08-22 |
Amersham Pharm Biotech Uk Ltd |
Chemical capture reagent
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
DK1578771T3
(da)
|
2001-10-10 |
2013-06-10 |
Novo Nordisk As |
Remodellering og glycokonjugering af peptider
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
CN105131104B
(zh)
|
2001-10-10 |
2018-11-16 |
诺和诺德公司 |
肽的重构和糖缀合
|
EP2298278B1
(de)
*
|
2002-06-07 |
2015-11-11 |
Dyax Corp. |
Verhinderung und Reduzierung von Blutverlust und Entzündungsreaktion
|
US7153829B2
(en)
|
2002-06-07 |
2006-12-26 |
Dyax Corp. |
Kallikrein-inhibitor therapies
|
US7217254B2
(en)
|
2002-09-20 |
2007-05-15 |
Genzyme Corporation |
Multi-pressure biocompatible agent delivery device and method
|
CA2502367C
(en)
|
2002-10-16 |
2013-12-10 |
Euro-Celtique S.A. |
Antibodies that bind cell-associated ca 125/o772p and methods of use thereof
|
US7311926B2
(en)
*
|
2002-12-20 |
2007-12-25 |
Battelle Memorial Institute |
Biocomposite materials and methods for making the same
|
JP2006523211A
(ja)
|
2003-03-14 |
2006-10-12 |
ネオス テクノロジーズ インコーポレイテッド |
分岐水溶性ポリマーとその複合物
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
EP2338333B1
(de)
|
2003-04-09 |
2017-09-06 |
ratiopharm GmbH |
Glycopegylierungsverfahren und durch die Verfahren hergestellte Proteine/Peptide
|
WO2004103275A2
(en)
|
2003-05-09 |
2004-12-02 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of human growth hormone glycosylation mutants
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
PT1663281E
(pt)
*
|
2003-08-29 |
2014-03-17 |
Dyax Corp |
Inibidores de proteases poli-peguilados
|
US7786213B2
(en)
*
|
2003-10-15 |
2010-08-31 |
The Regents Of The University Of California |
Biomacromolecule polymer conjugates
|
EP1680443B9
(de)
|
2003-11-05 |
2014-09-03 |
Dana-Farber Cancer Institute, Inc. |
Peptide mit stabilisierter alpha-helix und deren verwendungen
|
US7842661B2
(en)
|
2003-11-24 |
2010-11-30 |
Novo Nordisk A/S |
Glycopegylated erythropoietin formulations
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
US7956032B2
(en)
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
ES2392061T3
(es)
*
|
2003-12-22 |
2012-12-04 |
Regentis Biomaterials Ltd. |
Matriz que comprende un esqueleto proteico de origen natural reticulado
|
US7842667B2
(en)
|
2003-12-22 |
2010-11-30 |
Regentis Biomaterials Ltd. |
Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
|
ES2560657T3
(es)
|
2004-01-08 |
2016-02-22 |
Ratiopharm Gmbh |
Glicosilación con unión en O de péptidos G-CSF
|
WO2005115477A2
(en)
|
2004-04-13 |
2005-12-08 |
Quintessence Biosciences, Inc. |
Non-natural ribonuclease conjugates as cytotoxic agents
|
ATE385423T1
(de)
|
2004-06-16 |
2008-02-15 |
Straumann Holding Ag |
Abdeckmembran
|
US7282584B2
(en)
|
2004-06-16 |
2007-10-16 |
Straumann Holding Ag |
Methylene blue
|
EP2594291A1
(de)
|
2004-07-05 |
2013-05-22 |
Ascendis Pharma GmbH |
Hydrogel
|
EP1625856A1
(de)
*
|
2004-08-13 |
2006-02-15 |
Complex Biosystems GmbH |
Hydrogel Polymer Prodroge Konjugate
|
US7968085B2
(en)
*
|
2004-07-05 |
2011-06-28 |
Ascendis Pharma A/S |
Hydrogel formulations
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
EP1799249A2
(de)
|
2004-09-10 |
2007-06-27 |
Neose Technologies, Inc. |
Glycopegyliertes interferon alpha
|
US7235530B2
(en)
|
2004-09-27 |
2007-06-26 |
Dyax Corporation |
Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
|
SI2586456T1
(sl)
|
2004-10-29 |
2016-05-31 |
Ratiopharm Gmbh |
Preoblikovanje in glikopegliacija fibroblastnega rastnega faktorja (FGF)
|
EP1858543B1
(de)
|
2005-01-10 |
2013-11-27 |
BioGeneriX AG |
Glycopegylierten Granulocyten-Kolonie-stimulierender Faktor
|
WO2006086510A2
(en)
|
2005-02-09 |
2006-08-17 |
Tyco Healthcare Group Lp |
Synthetic sealants
|
US20060222596A1
(en)
|
2005-04-01 |
2006-10-05 |
Trivascular, Inc. |
Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
|
US7517914B2
(en)
|
2005-04-04 |
2009-04-14 |
Boston Scientificscimed, Inc. |
Controlled degradation materials for therapeutic agent delivery
|
WO2006121569A2
(en)
|
2005-04-08 |
2006-11-16 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
EP2975135A1
(de)
|
2005-05-25 |
2016-01-20 |
Novo Nordisk A/S |
Glykopegylierter Faktor IX
|
WO2007008300A2
(en)
|
2005-05-31 |
2007-01-18 |
ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE |
Triblock copolymers for cytoplasmic delivery of gene-based drugs
|
WO2007007392A1
(ja)
*
|
2005-07-11 |
2007-01-18 |
Wako Pure Chemical Industries, Ltd. |
新規ポリマー及びこれを用いたコレステロール測定法
|
US8568705B2
(en)
|
2005-07-18 |
2013-10-29 |
Nektar Therapeutics |
Method for preparing branched functionalized polymers using branched polyol cores
|
GB0515625D0
(en)
*
|
2005-07-29 |
2005-09-07 |
Univ Manchester |
Hydrogel particle
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
JP2007112924A
(ja)
*
|
2005-10-21 |
2007-05-10 |
National Institute For Materials Science |
高分子架橋剤及びこの架橋剤を用いたリポソーム又は細胞の架橋体
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
WO2007127198A2
(en)
|
2006-04-24 |
2007-11-08 |
Incept, Llc |
Protein crosslinkers, crosslinking methods and applications thereof
|
US7872068B2
(en)
|
2006-05-30 |
2011-01-18 |
Incept Llc |
Materials formable in situ within a medical device
|
JP2009541333A
(ja)
|
2006-06-23 |
2009-11-26 |
クインテセンス バイオサイエンシーズ インコーポレーティッド |
修飾リボヌクレアーゼ
|
EP2049151A4
(de)
*
|
2006-07-17 |
2010-03-24 |
Quintessence Biosciences Inc |
Verfahren und zusammensetzungen zur behandlung von krebs
|
CN101516388B
(zh)
|
2006-07-21 |
2012-10-31 |
诺和诺德公司 |
通过o-联糖基化序列的肽的糖基化
|
US8268948B2
(en)
|
2006-07-21 |
2012-09-18 |
Nektar Therapeutics |
Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom
|
AU2007314501B2
(en)
|
2006-09-28 |
2013-05-23 |
Merck Sharp & Dohme Corp. |
Use of pegylated IL-10 to treat cancer
|
EP2054521A4
(de)
|
2006-10-03 |
2012-12-19 |
Novo Nordisk As |
Verfahren zur reinigung von polypeptid-konjugate
|
CN101600448B
(zh)
|
2006-10-04 |
2015-11-25 |
诺和诺德公司 |
甘油连接的peg化的糖和糖肽
|
US8394483B2
(en)
|
2007-01-24 |
2013-03-12 |
Micron Technology, Inc. |
Two-dimensional arrays of holes with sub-lithographic diameters formed by block copolymer self-assembly
|
JP5649825B2
(ja)
|
2007-01-31 |
2015-01-07 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
安定化させたp53ペプチドおよびその使用法
|
US8083953B2
(en)
|
2007-03-06 |
2011-12-27 |
Micron Technology, Inc. |
Registered structure formation via the application of directed thermal energy to diblock copolymer films
|
US8557128B2
(en)
|
2007-03-22 |
2013-10-15 |
Micron Technology, Inc. |
Sub-10 nm line features via rapid graphoepitaxial self-assembly of amphiphilic monolayers
|
ES2430067T3
(es)
|
2007-03-28 |
2013-11-18 |
President And Fellows Of Harvard College |
Polipéptidos cosidos
|
ES2406267T3
(es)
|
2007-04-03 |
2013-06-06 |
Biogenerix Ag |
Métodos de tratamiento usando G-CSF glicopegilado
|
US8294139B2
(en)
|
2007-06-21 |
2012-10-23 |
Micron Technology, Inc. |
Multilayer antireflection coatings, structures and devices including the same and methods of making the same
|
US7959975B2
(en)
|
2007-04-18 |
2011-06-14 |
Micron Technology, Inc. |
Methods of patterning a substrate
|
US8097175B2
(en)
|
2008-10-28 |
2012-01-17 |
Micron Technology, Inc. |
Method for selectively permeating a self-assembled block copolymer, method for forming metal oxide structures, method for forming a metal oxide pattern, and method for patterning a semiconductor structure
|
US8372295B2
(en)
|
2007-04-20 |
2013-02-12 |
Micron Technology, Inc. |
Extensions of self-assembled structures to increased dimensions via a “bootstrap” self-templating method
|
US20080287633A1
(en)
*
|
2007-05-18 |
2008-11-20 |
Drumheller Paul D |
Hydrogel Materials
|
US8404124B2
(en)
|
2007-06-12 |
2013-03-26 |
Micron Technology, Inc. |
Alternating self-assembling morphologies of diblock copolymers controlled by variations in surfaces
|
WO2008154639A2
(en)
|
2007-06-12 |
2008-12-18 |
Neose Technologies, Inc. |
Improved process for the production of nucleotide sugars
|
US8080615B2
(en)
|
2007-06-19 |
2011-12-20 |
Micron Technology, Inc. |
Crosslinkable graft polymer non-preferentially wetted by polystyrene and polyethylene oxide
|
US20090075887A1
(en)
*
|
2007-08-21 |
2009-03-19 |
Genzyme Corporation |
Treatment with Kallikrein Inhibitors
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
CA2702043A1
(en)
*
|
2007-10-08 |
2009-04-16 |
Quintessence Biosciences, Inc. |
Compositions and methods for ribonuclease-based therapies
|
US8999492B2
(en)
|
2008-02-05 |
2015-04-07 |
Micron Technology, Inc. |
Method to produce nanometer-sized features with directed assembly of block copolymers
|
US8101261B2
(en)
|
2008-02-13 |
2012-01-24 |
Micron Technology, Inc. |
One-dimensional arrays of block copolymer cylinders and applications thereof
|
EP2247645B1
(de)
*
|
2008-02-13 |
2017-12-06 |
Hyperbranch Medical Technology, Inc. |
Vernetzte polyalkylenimin-hydrogele mit einstellbaren degradationsraten
|
JP5150297B2
(ja)
*
|
2008-02-14 |
2013-02-20 |
ネクター セラピューティックス エイエル,コーポレイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
PL2257311T3
(pl)
|
2008-02-27 |
2014-09-30 |
Novo Nordisk As |
Koniugaty cząsteczek czynnika VIII
|
US8425982B2
(en)
|
2008-03-21 |
2013-04-23 |
Micron Technology, Inc. |
Methods of improving long range order in self-assembly of block copolymer films with ionic liquids
|
US8426313B2
(en)
|
2008-03-21 |
2013-04-23 |
Micron Technology, Inc. |
Thermal anneal of block copolymer films with top interface constrained to wet both blocks with equal preference
|
US8114300B2
(en)
|
2008-04-21 |
2012-02-14 |
Micron Technology, Inc. |
Multi-layer method for formation of registered arrays of cylindrical pores in polymer films
|
US8114301B2
(en)
|
2008-05-02 |
2012-02-14 |
Micron Technology, Inc. |
Graphoepitaxial self-assembly of arrays of downward facing half-cylinders
|
WO2010014258A2
(en)
*
|
2008-08-01 |
2010-02-04 |
Nektar Therapeutics Al, Corporation |
Conjugates having a releasable linkage
|
JP5435536B2
(ja)
*
|
2008-09-04 |
2014-03-05 |
学校法人神奈川大学 |
光分解性ブロックコポリマー
|
CN104961795A
(zh)
|
2008-09-22 |
2015-10-07 |
爱勒让治疗公司 |
用于制备纯化的多肽组合物的方法
|
WO2010039985A1
(en)
|
2008-10-01 |
2010-04-08 |
Quintessence Biosciences, Inc. |
Therapeutic Ribonucleases
|
EP2356228B1
(de)
|
2008-11-25 |
2023-05-03 |
École Polytechnique Fédérale de Lausanne (EPFL) |
Blockcopolymere und verwendungen davon
|
WO2010067378A2
(en)
|
2008-12-08 |
2010-06-17 |
Reliance Life Sciences Pvt. Ltd. |
Hydrogel composition
|
AU2010203712A1
(en)
|
2009-01-06 |
2010-07-15 |
Dyax Corp. |
Treatment of mucositis with kallikrein inhibitors
|
JP2012515172A
(ja)
|
2009-01-14 |
2012-07-05 |
エルロン・セラピューティクス・インコーポレイテッド |
ペプチド模倣大環状分子
|
US8409606B2
(en)
|
2009-02-12 |
2013-04-02 |
Incept, Llc |
Drug delivery through hydrogel plugs
|
CA2760704C
(en)
|
2009-05-04 |
2017-10-03 |
Incept, Llc |
Biomaterials for track and puncture closure
|
NZ597022A
(en)
|
2009-06-09 |
2014-05-30 |
Prolong Pharmaceuticals Llc |
Hemoglobin compositions
|
WO2011012718A1
(en)
|
2009-07-31 |
2011-02-03 |
Ascendis Pharma As |
Prodrugs comprising an insulin linker conjugate
|
BR112012001988A2
(pt)
|
2009-07-31 |
2017-05-09 |
Sanofi Aventis Deutschland |
composição de insulina de ação prolongada
|
JP4704506B2
(ja)
*
|
2009-08-11 |
2011-06-15 |
財団法人川村理化学研究所 |
有機無機複合ヒドロゲルおよびその製造方法
|
JP2013505300A
(ja)
|
2009-09-22 |
2013-02-14 |
エルロン・セラピューティクス・インコーポレイテッド |
ペプチド模倣大環状分子
|
US20110081398A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Tyco Healthcare Group Lp |
Multi-mechanism surgical compositions
|
US8968785B2
(en)
*
|
2009-10-02 |
2015-03-03 |
Covidien Lp |
Surgical compositions
|
US20110081701A1
(en)
*
|
2009-10-02 |
2011-04-07 |
Timothy Sargeant |
Surgical compositions
|
JP5552310B2
(ja)
*
|
2009-12-24 |
2014-07-16 |
日清紡ホールディングス株式会社 |
樹脂架橋剤
|
RS62853B1
(sr)
|
2010-01-06 |
2022-02-28 |
Takeda Pharmaceuticals Co |
Proteini koji vezuju kalikrein plazme
|
US8524215B2
(en)
*
|
2010-08-02 |
2013-09-03 |
Janssen Biotech, Inc. |
Absorbable PEG-based hydrogels
|
KR20170058446A
(ko)
|
2010-08-13 |
2017-05-26 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티도미메틱 거대고리
|
US8304493B2
(en)
|
2010-08-20 |
2012-11-06 |
Micron Technology, Inc. |
Methods of forming block copolymers
|
EP2438930A1
(de)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrug mit einem exendinbindenden Konjugat
|
JP2014502152A
(ja)
|
2010-11-12 |
2014-01-30 |
ダナ ファーバー キャンサー インスティテュート,インコーポレイテッド |
癌の治療及び診断
|
AU2012204202A1
(en)
|
2011-01-06 |
2013-07-11 |
Dyax Corp. |
Plasma kallikrein binding proteins
|
RU2639523C2
(ru)
|
2011-10-18 |
2017-12-21 |
Эйлерон Терапьютикс, Инк. |
Пептидомиметические макроциклы и их применение
|
US8900963B2
(en)
|
2011-11-02 |
2014-12-02 |
Micron Technology, Inc. |
Methods of forming semiconductor device structures, and related structures
|
EP2858661B1
(de)
|
2011-12-29 |
2020-04-22 |
Dana-Farber Cancer Institute, Inc. |
Stabilisierte antivirale fusionsspiralen
|
CA2862038C
(en)
|
2012-02-15 |
2021-05-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CA2864120A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
JP5953459B2
(ja)
*
|
2012-03-27 |
2016-07-20 |
ネクター セラピューティクス |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
DK2920197T3
(da)
|
2012-09-26 |
2021-05-31 |
Harvard College |
Prolinlåste sammenhæftede peptider og anvendelser deraf
|
US9087699B2
(en)
|
2012-10-05 |
2015-07-21 |
Micron Technology, Inc. |
Methods of forming an array of openings in a substrate, and related methods of forming a semiconductor device structure
|
JP6526563B2
(ja)
|
2012-11-01 |
2019-06-05 |
エイルロン セラピューティクス,インコーポレイテッド |
二置換アミノ酸ならびにその調製および使用の方法
|
SG10201700952XA
(en)
|
2013-03-13 |
2017-04-27 |
Harvard College |
Stapled and stitched polypeptides and uses thereof
|
EP2971010B1
(de)
|
2013-03-14 |
2020-06-10 |
ModernaTX, Inc. |
Formulierung und abgabe von modifizierten nukleosid-, nukleotid- und nukleinsäurezusammensetzungen
|
US10308926B2
(en)
|
2013-03-15 |
2019-06-04 |
Dana-Farber Cancer Institute, Inc. |
Stablized EZH2 peptides
|
US10106590B2
(en)
|
2013-03-15 |
2018-10-23 |
Dana-Farber Cancer Institute, Inc. |
BH4 stabilized peptides and uses thereof
|
US10087215B2
(en)
|
2013-03-15 |
2018-10-02 |
Dana-Farber Cancer Institute, Inc. |
Stabilized SOS1 peptides
|
US9943568B2
(en)
|
2013-04-18 |
2018-04-17 |
Armo Biosciences, Inc. |
Methods of using pegylated interleukin-10 for treating cancer
|
US9229328B2
(en)
|
2013-05-02 |
2016-01-05 |
Micron Technology, Inc. |
Methods of forming semiconductor device structures, and related semiconductor device structures
|
US10227390B2
(en)
|
2013-06-14 |
2019-03-12 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
ES2688206T3
(es)
|
2013-06-17 |
2018-10-31 |
Armo Biosciences, Inc. |
Procedimiento de evaluación de la identidad y la estabilidad de proteínas
|
US10711106B2
(en)
|
2013-07-25 |
2020-07-14 |
The University Of Chicago |
High aspect ratio nanofibril materials
|
AU2014315287A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
EP3041938A1
(de)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Kreisförmige polynukleotide
|
US9177795B2
(en)
|
2013-09-27 |
2015-11-03 |
Micron Technology, Inc. |
Methods of forming nanostructures including metal oxides
|
WO2015070060A1
(en)
|
2013-11-11 |
2015-05-14 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
CN106459210A
(zh)
|
2014-03-27 |
2017-02-22 |
戴埃克斯有限公司 |
用于治疗糖尿病黄斑性水肿的组合物和方法
|
JP7059003B2
(ja)
|
2014-05-14 |
2022-04-25 |
トラスティーズ・オブ・ダートマス・カレッジ |
脱免疫化リゾスタフィン及び使用方法
|
US10533039B2
(en)
|
2014-05-21 |
2020-01-14 |
President And Fellows Of Harvard College |
Ras inhibitory peptides and uses thereof
|
US10293043B2
(en)
|
2014-06-02 |
2019-05-21 |
Armo Biosciences, Inc. |
Methods of lowering serum cholesterol
|
CA2961029A1
(en)
|
2014-09-24 |
2016-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and formulations thereof
|
MX2017003797A
(es)
|
2014-09-24 |
2017-06-15 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos y usos de los mismos.
|
AU2015336101A1
(en)
|
2014-10-22 |
2017-04-20 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
US10618970B2
(en)
|
2015-02-03 |
2020-04-14 |
Armo Biosciences, Inc. |
Method of treating cancer with IL-10 and antibodies that induce ADCC
|
AU2016232833A1
(en)
|
2015-03-18 |
2017-10-12 |
Dana-Farber Cancer Institute, Inc. |
Selective Mcl-1 binding peptides
|
CN107614003A
(zh)
|
2015-03-20 |
2018-01-19 |
艾瑞朗医疗公司 |
拟肽大环化合物及其用途
|
EP3302547A1
(de)
|
2015-05-28 |
2018-04-11 |
Armo Biosciences, Inc. |
Pegyliertes interleukin-10 zur behandlung von krebs
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
JP6918712B2
(ja)
|
2015-07-02 |
2021-08-11 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
安定化抗微生物性ペプチド
|
EP3341012A4
(de)
|
2015-08-25 |
2019-03-20 |
Armo Biosciences, Inc. |
Verfahren zur verwendung von interleukin-10 zur behandlung von erkrankungen und leiden
|
US11078246B2
(en)
|
2015-08-28 |
2021-08-03 |
Dana-Farber Cancer Institute, Inc. |
Peptides binding to Bfl-1
|
US10023613B2
(en)
|
2015-09-10 |
2018-07-17 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of MCL-1
|
JP6184462B2
(ja)
*
|
2015-10-28 |
2017-08-23 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
US11286307B2
(en)
|
2015-12-11 |
2022-03-29 |
Takeda Pharmaceutical Company Limited |
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
|
JP7105696B2
(ja)
|
2016-02-29 |
2022-07-25 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド
|
US11198715B2
(en)
|
2016-07-22 |
2021-12-14 |
Massachusetts Institute Of Technology |
Selective Bfl-1 peptides
|
US11466064B2
(en)
|
2016-08-26 |
2022-10-11 |
Dana-Farber Cancer Institute, Inc. |
Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss
|
WO2018170299A1
(en)
|
2017-03-15 |
2018-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibitors of prokaryotic gene transcription and uses thereof
|
JP6361083B2
(ja)
*
|
2017-06-27 |
2018-07-25 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
WO2019018499A2
(en)
|
2017-07-19 |
2019-01-24 |
Dana-Farber Cancer Institute, Inc. |
ANTIMICROBIAL PEPTIDES STABILIZED FOR THE TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIAL INFECTIONS
|
EP3678484A4
(de)
|
2017-09-07 |
2021-03-24 |
KindHeart, Inc |
Modifizierte tierorgane zur verwendung in chirurgischen simulatoren
|
CA3079758A1
(en)
|
2017-12-15 |
2019-06-20 |
Dana-Farber Cancer Institute, Inc. |
Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive noxa peptides
|
AU2018385697B2
(en)
|
2017-12-15 |
2023-11-09 |
Dana-Farber Cancer Institute, Inc. |
Stabilized peptide-mediated targeted protein degradation
|
CA3089279A1
(en)
|
2018-02-07 |
2019-08-15 |
Dana-Farber Cancer Institute, Inc. |
Cell-permeable stapled peptide modules for cellular delivery
|
WO2019178313A1
(en)
|
2018-03-14 |
2019-09-19 |
Dana-Farber Cancer Institute, Inc. |
Stabilized peptides for biomarker detection
|
JP6500318B2
(ja)
*
|
2018-04-04 |
2019-04-17 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
US11286299B2
(en)
|
2018-09-17 |
2022-03-29 |
Massachusetts Institute Of Technology |
Peptides selective for Bcl-2 family proteins
|
CA3135115A1
(en)
|
2019-04-18 |
2020-10-22 |
Dana-Farber Cancer Institute, Inc. |
Selective targeting of ubiquitin- and ubiquitin-like e1-activating enzymes by structurally-stabilized peptides
|
CN110668933A
(zh)
*
|
2019-09-30 |
2020-01-10 |
兰州交通大学 |
一种合成烯丙基脂肪醇聚氧乙烯醚羧酸(apea-7)的新方法
|
CN110759824A
(zh)
*
|
2019-09-30 |
2020-02-07 |
兰州交通大学 |
一种合成烯丙基脂肪醇聚氧乙烯醚羧酸(apea-3)的新方法
|
AU2020404876A1
(en)
|
2019-12-16 |
2022-07-21 |
Dana-Farber Cancer Institute, Inc. |
Structurally-stabilized oncolytic peptides and uses thereof
|
AU2020408070A1
(en)
|
2019-12-20 |
2022-06-09 |
Dana-Farber Cancer Institute, Inc. |
Structurally-stabilized glucagon-like peptide 1 peptides and uses thereof
|
CN115811984A
(zh)
|
2020-03-04 |
2023-03-17 |
丹娜法伯癌症研究院 |
抗病毒的结构上稳定的SARS-CoV-2肽和其用途
|
WO2021216845A1
(en)
|
2020-04-22 |
2021-10-28 |
Dana-Farber Cancer Institute, Inc. |
Antiviral structurally-stabilized ace2 helix 1 peptides and uses thereof
|
US20230192789A1
(en)
|
2020-04-27 |
2023-06-22 |
Dana-Farber Cancer Institute, Inc. |
Structurally-stabilized and hdmx-selective p53 peptides and uses thereof
|
WO2022081827A1
(en)
|
2020-10-14 |
2022-04-21 |
Dana-Farber Cancer Institute, Inc. |
Chimeric conjugates for degradation of viral and host proteins and methods of use
|
US20240002450A1
(en)
|
2020-11-05 |
2024-01-04 |
Dana-Farber Cancer Institute, Inc. |
Antiviral structurally-stabilized ebolavirus peptides and uses thereof
|
AU2022341116A1
(en)
|
2021-09-08 |
2024-03-21 |
Dana-Farber Cancer Institute, Inc. |
Antiviral structurally-stapled sars-cov-2 peptide- cholesterol conjugates and uses thereof
|
WO2023215784A1
(en)
|
2022-05-04 |
2023-11-09 |
Dana-Farber Cancer Institute, Inc. |
Ebolavirus surface glycoprotein peptides, conjugates, and uses thereof
|